Comparison of c-myc expression in normal human bronchial epithelial cells and lung cancer cell lines using a quantitative fluorescence-based reverse transcriptase-polymerase chain reaction method

Toxicology Methods

Volumn 9, Issue 3, 1999, Pages 173-188

  Fields, Wanda R ^a,b   Bombick, David W ^b   Desiderio, Joseph G ^b   Doolittle, David J ^a,b  

^a DUKE UNIVERSITY   (United States)

^b R J REYNOLDS TOBACCO COMPANY   (United States)

Author keywords

c myc; Lung; mRNA; Oncogene; Quantitative RT PCR

Indexed keywords

ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; DIAGNOSTIC VALUE; DNA DETERMINATION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; LUNG CANCER; ONCOGENE C MYC; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TUMOR SUPPRESSOR GENE;

BRONCHUS;

EID: 0032849303     PISSN: 10517235     EISSN: None     Source Type: Journal    
DOI: 10.1080/105172399242681     Document Type: Article

References (55)

1. Saurez HG. Activated oncogenes in human tumors. Anticancer Res. 1989;9:1331-1334.
2. Kashii T, Mizushima Y, Nakagawa K, Kobayshi M. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method. J Cancer Res Clin Oncol. 1994;120: 143-148.
3. Takahashi T, Nau MM, Chiba I, et al. P53: a frequent target for genetic abnormalities in lung cancer. Science. 1982;246:491-494.
4. Gazdar AF. The molecular biology of lung cancer. Tohoku J Exp Med. 1992;168:239-245.
5. Gazdar AF, Bader S, Hung J, et al. Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harbor Symposia on Quantitative Biology. 1994;59:565-572.
6. Sugi K, Kishimoto Y, Virmani AK, Hung JY, Gazdar AF. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res. 1994;54:5811-5815.
7. Johnson BE, Ihde DC, Makuch RW, et al. Myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J Clin Invest. 1987;79:1629-1634.
8. Prins J, De Vries EGE, Mulder NH. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumor types. Anticancer Res. 1993;13: 1373-1386.
9. Mace K, Gonzalez FJ, McConnell IR, et al. Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2. Mol Carcinog. 1994;11: 65-73.
10. Sozzi G, Miozzo M, Tagliabue E, et al. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res. 1991;51:400-404.
11. Saccomanno G, Arcer VE, Auerbach O, Saunders RP, Brenan LM. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer. 1974;33:256-270.
12. Sozzi G, Miozzo M, Donghi S, et al. Deletions of 17p and p53 mutations in preneoplastic lessions of the lung. Cancer Res. 1992;52:6079-6082.
13. Cotran RS, Kumar V, Robbins SL. Pathologic Basis of Disease. Philadelphia: Saunders; 1994.
14. Williams C. Lung Cancer: The Facts. New York: Oxford University Press; 1997.
15. 1 transition in nontransformed cells. Cell Growth Different. 1993;4:93-104.
16. Freytag SO. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell Biol. 1988;8:1614-1624.
17. Lechner JF, LaVeck MA. A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J Tissue Cult Methods. 1985;9:43-48.
18. Livak K, Marmar J, Flood S. Guidelines for designing TaqMan fluorogenic probes for 5′ nuclease assays. Perkin Elmer Res News. 1995c;1-5.
19. Livak KJ, Flood SJ, Marmaro J, et al. Oligonucleotides with fluorogenic dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 1995;4:357-362.
20. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5'-3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA. 1991;88:7276-7280.
21. Noonan KE, Beck C, Holzmayer TA, et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA. 1990;87:7160-7164.
22. Salomon RN, Underwood R, Doyle MV, Wang A, Libby P. Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc Natl Acad Sci USA. 1992;89:2814-2818.
23. Facchini LM, Penn LZ. The molecular role of myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 1998;12:633-651.
24. Evan G, Harrington E, Fanidi A, Land H, Amati B, Bennett M. Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos Trans R Soc Lond B Biol Sci. 1994;345:268-275
25. Littlewood TD, Evan GI. The role of myc oncogenes in cell growth and differentiation. Adv Dent Res. 1990;4:69-79.
26. Ryan KM, Birnie GD. Myc oncogenes: the enigmatic family. Biochem J. 1996;314:713-721.
27. Seth A, Gupta S, Davis RJ. Cell cycle regulation of the c-myc transcriptional activation domain. Mol Cell Biol. 1993;13:4125-4136.
28. Kiefer P, Bepler G, Kubash M, Haveman K. Amplification and expression of protooncogenes in human small cell lung cancer lines. Cancer Res. 1987;47:6236-6242.
29. Prins J, DeVries EGE, Mulder NH. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumor types. Anticancer Res. 1993;13:1373-1386.
30. Guerin M, Barrios M, Terrier MJ, Spielmann M, Riou G. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res. 1988;3:21-31.
31. Mariani-Costantini R, Escot C, Theillet C, et al. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res. 1988;48:199-205.
32. Ocadiz R, Sauceda R. Cruz M, Graef AM, Gariglio P. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. Cancer Res. 1987;47:4173-4177.
33. Symonds G, Hartshorn A, Kennewell A, O'Mara MA, Bruskin A, Bishop JM. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential. Oncogene. 1989;4:285-294.
34. Berns A, Breuer M, Verbeek S, Lohuizen M. Transgenic mice as a means to study synergism between oncogenes. Int J Cancer Suppl. 1989;4:22-25.
35. Willey JC, Coy EL, Frampton MW, et al. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am J Respir Cell Mol Biol. 1997;17:114-124.
36. Willey JC, Coy E, Brolly C, et al. Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am J Respir Cell Mol Biol. 1996;14: 262-271.
37. Feo S, Di Liergro C, Jones T, Read M, Fried M. The DNA region around the c-myc gene and its amplification in human tumor cell lines. Oncogene. 1994;9:955-961.
38. Gazdar AF, Carney DN, Nau MM, Minna JD. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res. 1985;45:2924-2930.
39. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature. 1983;306:194-196.
40. Johnson BE, Brennan JF, Ihde DC, Gazdar AF. myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer. Natl Cancer Inst Monogr. 1992;13: 39-43.
41. Johnson BE, Makuck RW, Simmons AD, Gazdar AF, Burch D, Cashell AW. c-myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Cancer Res. 1988;48:5163-5166.
42. Saksela K, Bergh J, Lehto V, Nilsson K, Alitalo K. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Cancer Res. 1985;45:1823-1827.
43. Yoshimoto K, Hiroashi S, Sekiya T. Increased expression of the c-myc gene without gene amplification in human lung cancer and colon cancer cell lines. Jpn J Cancer Res. 1986;77: 540-545.
44. Seifter EJ, Sausville EA, Battey J. Comparison of amplified and unamplified c-myc gene structure and expression in human small cell lung carcinoma cell lines. Cancer Res. 1986;46: 2050-2055.
45. Broers JLV, Viallet J, Jensen SM, et al. Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers. Am J Respir Cell Mol Biol. 1993;9:33-43.
46. Willey JC, Crawford EL, Jackson CM, et al. Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates. Am J Respir Cell Mol Biol. 1998;19:6-17.
47. Ferre F, Marchese A, Pexxoli P, Griffin S, Buxton E, Boyer V. Quantitative PCR: an overview. In: Mullis KB, Gibbs RA, eds. The Polymerase Chain Reaction. Boston: Birkhauser; 1994:67-88.
48. Ferre F. Quantitative or semi-quantitative PCR: reality versus myth. PCR Methods Appl. 1992;2:1-9.
49. Zimmerman K, Mannhalter JW. Technical aspects of quantitative competitive PCR. Biotechniques. 1996;21:268-272.
50. Souaze F, Ntodou-Thome A, Tran CY, Rostene W, Forgez P. Quantitative RT-PCR: limits and accuracy. Biotechniques. 1996;21:280-285.
51. Morrison C, Gannon F. The impact of the PCR plateau phase on quantitative PCR. Biochim Biophys Acta. 1994;1219:493-498.
52. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology. 1993;11:1026-1030.
53. Gibson UE, Heid CA, William PM. A novel method for real time quantitative RT-PCR. Genome Res. 1996;6:995-1001.
54. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Methods. 1996;6:986-994.
55. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques. 1997;22:130-138.